KYNTRA BIO, INC. (KYNB) Net margin 2016–2025
KYNTRA BIO, INC. (KYNB) net profit margin by fiscal year — reported net income divided by reported revenue.
2848.6%FY2025 · since FY2016: -31.7% → 2848.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2848.6% | +3009.3 pp |
| FY2024 | -160.6% | +446.7 pp |
| FY2023 | -607.3% | -398.6 pp |
| FY2022 | -208.7% | -85.4 pp |
| FY2021 | -123.3% | -15.9 pp |
| FY2020 | -107.4% | -77.4 pp |
| FY2019 | -30.0% | +10.6 pp |
| FY2018 | -40.6% | +51.7 pp |
| FY2017 | -92.3% | -60.6 pp |
| FY2016 | -31.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice